Frontlight ResearchEarly access
Trial site
Institute of Science Tokyo Hospital
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease3 trials
- Fatty liver disease (MASLD/MASH)1 trial
- Psoriatic arthritis1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Lead sponsor
- Eli Lilly and Company5 trials
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 trial
Running trials
Recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Recruiting
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease2 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Psoriatic arthritis1 recruiting
- Ulcerative colitis1 recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026